|
1
|
Damron TA, Ward WG and Stewart A:
Osteosarcoma, chondrosarcoma, and Ewing's sarcoma: National Cancer
Data Base Report. Clin Orthop Relat Res. 459:40–47. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Canale ST and Beaty JH: Campbell's
Operative Orthopaedics (12th). Philadelphia, PA: Elsevier. 2013.
View Article : Google Scholar
|
|
3
|
Briccoli A, Rocca M, Salone M, Guzzardella
GA, Balladelli A and Bacci G: High grade osteosarcoma of the
extremities metastatic to the lung: long-term results in 323
patients treated combining surgery and chemotherapy, 1985–2005.
Surg Oncol. 19:193–199. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Ottaviani G and Jaffe N: The epidemiology
of osteosarcoma. Cancer Treat Res. 152:3–13. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Marulanda GA, Henderson ER, Johnson DA,
Letson GD and Cheong D: Orthopedic surgery options for the
treatment of primary osteosarcoma. Cancer Control. 15:13–20.
2008.PubMed/NCBI
|
|
6
|
Jaffe N: Osteosarcoma: Review of the past,
impact on the future. The American experience. Cancer Treat Res.
152:239–262. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Goorin AM, Schwartzentruber DJ, Devidas M,
et al: Presurgical chemotherapy compared with immediate surgery and
adjuvant chemotherapy for nonmetastatic osteosarcoma: Pediatric
oncology group study POG-8651. J Clin Oncol. 21:1574–1580. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Arpaci F, Ataergin S, Ozet A, et al: The
feasibility of neoadjuvant high-dose chemotherapy and autologous
peripheral blood stem cell transplantation in patients with
nonmetastatic high grade localized osteosarcoma: Results of a phase
II study. Cancer. 104:1058–1065. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Bacci G, Forni C, Longhi A, Ferrari S,
Mercuri M, Bertoni F, Serra M, Briccoli A, Balladelli A and Picci
P: Local recurrence and local control of non-metastatic
osteosarcoma of the extremities: A 27-year experience in a single
institution. J Surg Oncol. 96:118–123. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Bramer JA, Van Linge JH, Grimer RJ and
Scholten RJ: Prognostic factors in localized extremity
osteosarcoma: A systematic review. Eur J Surg Oncol. 35:1030–1036.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Clark JC, Dass CR and Choong PF: A review
of clinical and molecular prognostic factors in osteosarcoma. J
Cancer Res Clin Oncol. 134:281–297. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Bacci G, Longhi A, Versari M, Mercuri M,
Briccoli A and Picci P: Prognostic factors for osteosarcoma of the
extremity treated with neoadjuvant chemotherapy 15-year experience
in 789 patients treated at a single institution. Cancer.
106:1154–1161. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Bielack SS, Kempf-Bielack B, Delling G,
Exner GU, Flege S, Helmke K, Kotz R, Salzer-Kuntschik M, Werner M,
Winkelmann W, et al: Prognostic factors in high-grade osteosarcoma
of the extremities or trunk: An analysis of 1,702 patients treated
on neoadjuvant cooperative osteosarcoma study group protocols. J
Clin Oncol. 20:776–790. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Harting MT, Lally KP, Andrassy RJ,
Vaporciyan AA, Cox CS Jr, Hayes-Jordan A and Blakely ML: Age as a
prognostic factor for patients with osteosarcoma: An analysis of
438 patients. J Cancer Res Clin Oncol. 136:561–570. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Shalaby S, Shalaby H and Bassiony A: Limb
salvage for osteosarcoma of the distal tibia with resection
arthrodesis, autogenous fibular graft and llizarov external
fixator. J Bone Joint Surg Br. 88:1642–1646. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Smeland S, Müller C, Alvegard TA, Wiklund
T, Wiebe T, Björk O, Stenwig AE, Willén H, Holmström T, Follerås G,
et al: Scandinavian sarcoma group osteosarcoma study SSG VIII:
prognostic factors for out-come and the role of replacement salvage
chemotherapy for poor histological responders. Eur J Cancer.
39:488–494. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Davis AM, Bell RS and Goodwin PJ:
Prognostic factors in osteosarcoma: A critical review. J Clin
Oncol. 12:423–431. 1994.PubMed/NCBI
|
|
18
|
Manoso MW, Healey JH, Boland PJ,
Athanasian EA, Maki RG, Huvos AG and Morris CD: De novo osteogenic
sarcoma in patients older than forty: Benefit of multimodality
therapy. Clin Orthop Relat Res. 438:110–115. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Imran H, Enders F, Krailo M, Sim F, Okuno
S, Hawkins D, Neglia J, Randall RL, Womer R, Mascarenhas L and
Arndt CA: Effect of time to resumption of chemotherapy after
definitive surgery on prognosis for non-metastatic osteosarcoma. J
Bone Joint Surg Am. 91:604–612. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Ozaki T, Flege S, Kevric M, Lindner N,
Maas R, Delling G, Schwarz R, von Hochstetter AR, Salzer-Kuntschik
M, Berdel WE, et al: Osteosarcoma of the pelvis: Experience of the
cooperative osteosarcoma study group. J Clin Oncol. 21:334–341.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Nakase M, Inui M, Okumura K, Kamei T,
Nakamura S and Tagawa T: P53 gene therapy of human osteosarcoma
using a transferrin-modified cationic liposome. Mol Cancer Ther.
4:625–631. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Mori K, Rédini F, Gouin F, Cherrier B and
Heymann D: Osteosarcoma: Current status of immunotherapy and future
trends (Review). Oncol Rep. 15:693–700. 2006.PubMed/NCBI
|
